CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

Safety Evaluation of Sankhaholi (Evolvulus alsinoides Linn.) in the Management of Essential Hypertension: A Randomized Standard Control Trial

  • Received : 2019.09.06
  • Accepted : 2019.10.18
  • Published : 2019.11.29
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Hypertension is one of the major risk factors for stroke, heart attack, heart failure and kidney failure, thereby causing deaths and disability world-wide. The most predominant type of HTN is essential hypertension (HTN). Unani scholars have mentioned about the clinical manifestations and management of the hypertension and documented it in the context of 'Imtila'. The drug Sankhaholi (Evolvulus alsinoides Linn.) is one of the widely prescribed medicines for the management of essential hypertension in Unani medicine. Material and Methods: The present clinical study was carried out to evaluate the safety of Sankhaholi (Evolvulus alsinoides Linn.) in the management of stage-1 essential hypertension. Newly diagnosed 41 patients of Essential Hypertension (22 patients were in the test group and 19 patients in the control group) were enrolled for the study. All the patients in the test group were given with the test drug 3 g powder of Sankhaholi twice a day for 6 weeks orally. Patients in the control group were given standard drug Ramipril 5 mg once a day for the same duration. Clinical as well as hematological parameters were recorded before and after the treatment. Results: No significant changes are recorded in safety parameters viz. CBC, Haemogram, LFT and KFT. Clinically no adverse effect of the drug has been reported during the course of treatment. Also, significant effect on the systolic blood pressure (p<0.001) were recorded in test group. The drug Sankhaholi was also found effective on the symptoms associated with hypertension. Conclusion: The finding of the study revealed that the test drug Sankhaholi (Evolvulus alsinoides Linn.) is safe and has substantial efficacy as an antihypertensive drug.

Keywords

References

  1. Ausiello DA, Goldman L. Cecil Medicine. 23rd ed. (Philadelphia, USA:Saunders), 2007.
  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003:289(19):2560-72 https://doi.org/10.1001/jama.289.19.2560
  3. Ghani Najmul. Khazainul Advia. Tarjumn-u-Tib, (Lahore, Pakistan: Main Bazar Qasur Pura), YNM Vol-2, pp.963-964.
  4. Gupta P, Akanksha, Siripurapu KB, Ahmad A, Palit G, Arora A, Maurya R. Anti-stress constituents of Evolvulus alsinoides: An Ayurvedic Crude Drug. Chem Pharm Bull. 2007:55(5):771-5 https://doi.org/10.1248/cpb.55.771
  5. Joshi UH, Ganatra TH, Desai TR, Tirgar PR. Antihypertensive activity of Evolvulus alsinoides in adrenalin induced hypertension. International Journal of Pharmacy and Pharmaceutical Sciences. 2012:(4):194-98.
  6. Majoosi AIA. Kamelul Sana'at (Urdu translation).(New Delhi, Idara Kitabush-shifa), 2010
  7. Razi MA. Kitab-al-Murshid: (Urdu translation). (New Delhi. Taraqqi Urdu Bureau), 1996.
  8. Saranya B, Sarathatdevi D, Somasundaram SSN. Investigation of Antibacterial Activities of Evolvulus alsinoides (L.) against Clinical Pathogens. Int. J. Curr. Microbiol. App. Sci. 2015:4(5): 491-497.
  9. Shamsi Y, Ahmad J, Khan AA. A Clinical study on the management of anxiety neurosis with Sankhaholi. Indian Journal of Traditional Knowledge. 2007:6(4):668-677.
  10. Siripurapu KB, Gupta P, Bhatia G, Maurya R, Nath C, Palit G. Adaptogenic and anti-amnesic properties of Evolvulus alsinoides in rodents. Pharmacology Biochemistry and Behaviour. 2005: 81(3):424-432. https://doi.org/10.1016/j.pbb.2005.03.003